Chiral nanomaterials provide a rich platform for versatile applications. Tuning the wavelength of polarization rotation maxima in the broad range including short-wave infrared (SWIR) is a promising candidate for infrared neural stimulation, imaging, and nanothermometry. However, the majority of previously developed chiral nanomaterials reveal the optical activity in a relatively shorter wavelength range (ultraviolet−visible, UV−vis), not in SWIR. Here, we demonstrate a versatile method to synthesize chiral copper sulfides using cysteine, as the stabilizer, and transferring the chirality from molecular-to the microscale through self-assembly. The assembled structures show broad chiroptical activity in the UV− vis-NIR-SWIR region (200−2500 nm). Importantly, we can tune the chiroptical activity by simply changing the reaction conditions. This approach can be extended to materials platforms for developing next-generation optical devices, metamaterials, telecommunications, and asymmetric catalysts.
Research on chiral nanomaterials (NMs) has grown radically with a rapid increase in the number of publications over the past decade. It has attracted a large number of scientists in various fields predominantly because of the emergence of unprecedented electric, optical, and magnetic properties when chirality arises in NMs. For applications, it is particularly informative and fascinating to investigate how chiral NMs interact with electromagnetic waves and magnetic fields, depending on their intrinsic composition properties, atomic distortions, and assembled structures. This review provides an overview of recent advances in chiral NMs, such as semiconducting, metallic, and magnetic nanostructures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.